Neoplasms

Digestive System Diseases

All Conditions

Rectal Neoplasms

Colorectal Neoplasms

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Intestinal Diseases

Rectal Diseases

Robotic assisted transanal total mesorectal excision for rectal cancer patients

Laparoscopic transanal total mesorectal excision for rectal cancer patients

Robotic assisted transanal total mesorectal excision

Laparoscopic assisted transanal total mesorectal excision for rectal cancer patients

Laparoscopic assisted transanal total mesorectal excision

Weidong Tong, MD

Total mesorectal excision has greatly reduced the local recurrence rate of rectal cancer after colorectal surgery. Transanal total mesorectal excision(TaTME) is potentially a suitable option for patients with middle and low rectal cancer. Robotic systems are expected to develop the advantages of TaTME to overcome the limitations of laparoscopic surgery. This study aimed to investigate the safety and feasibility of robotic assisted transanal total mesorectal excision in patients with rectal cancer.

TaTME is potentially a suitable option for patients with middle or low rectal cancer, especially for males with obesity and a narrow pelvis.The da Vinci robotic system (Intuitive Surgical, Sunnyvale, CA, USA) is expected to overcome the limitations of the laparoscopic transanal approach for rectal surgery. Da Vinci Si Surgical System or da Vinci Xi Surgical System would be used to performed Transanal total mesorectal excision. And the surgery would performed by two-team approach. This study aimed to investigate the safety and feasibility of robotic assisted transanal total mesorectal excision in patients with rectal cancer.

Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer

The incidence of local recurrence rectal cancer within two years after surgery

The incidence of postoperative anastomotic leakage within 30 days after surgery

The 5-year survival rates of rectal cancer

The incidence of distant metastasis rectal cancer within two years after surgery

Third Military Medical University

Professor

Herbal and Botanical

All Drugs and Chemicals

Cola

Laparoscopic Assisted Transanal Total Mesorectal Excision

* Abdominal approach with laparoscopic mobilization of the left colon
* Laparoscopic isolation and transection of inferior mesenteric vessels .
* Transabdominal dissection of the upper rectum and mesorectam.
* Insertion of transanal platform and the creation of pneumorectum.
* Occlusion of rectum 2 cm distal to the rectal lesion via purse string.
* Transanal dissection of lower and mid mesorectam
* The specimen will be extracted transanally

mohamed abulfetouh, MD

samir a ali, PHD

samir a ali, phd

Rectal cancer is one of the frequent malignant neoplasms ,Total mesorectal excision (TME) has become the gold standard treatment for middle and lower rectal cancers. Laparoscopic TME still be difficult in patients with low rectal tumors, narrow pelvic anatomy, male sex or high body mass index . Difficult visualization of the pelvic anatomy along with the limitation of rigid laparoscopic instruments may affect the quality of oncological outcomes and increase the risks of injuries during surgery. A down to up approach via transanal total mesorectal excision (TaTME) technique may overcome these problems

This clinical trial will be conducted at general surgery department of Assiut University Hospital .

.

Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision

complication occured intraoperatively or on the first day of surgery

circumferential resection margin microscopic examination

manometric assessment of anorectal function

sexual function with IIEF(International Index of Erectile Function) questionnaire

The quality of the mesorectum or TME specimen(pathological examination)

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer	NCT04573738	Rectal Cancer Perioperative C...	Robotic assiste... Laparoscopic as...	18 Years - 80 Years	Third Military Medical University
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer	NCT04573738	Rectal Cancer Perioperative C...	Robotic assiste... Laparoscopic as...	18 Years - 80 Years	Third Military Medical University
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer	NCT04573738	Rectal Cancer Perioperative C...	Robotic assiste... Laparoscopic as...	18 Years - 80 Years	Third Military Medical University
Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision	NCT03171298	Rectal Cancer	Laparoscopic As...	18 Years -	Assiut University

Spots Global Cancer Trial Database for laparoscopic assisted transanal total mesorectal excision